Flupentixol



Indications and Reactions:

Role Indications Reactions
Secondary
Product Used For Unknown Indication 28.3%
Schizophrenia 14.5%
Prophylaxis 12.7%
Drug Use For Unknown Indication 10.2%
Foetal Exposure During Pregnancy 8.1%
Schizoaffective Disorder 7.1%
Psychotic Disorder 5.3%
Schizophrenia, Paranoid Type 3.9%
Depression 2.1%
Anxiety 1.4%
Bipolar Disorder 1.1%
Disseminated Tuberculosis 1.1%
Circulatory Collapse 0.7%
Insomnia 0.7%
Respiratory Failure 0.7%
Respiratory Rate Decreased 0.7%
Antidepressant Therapy 0.4%
Drug Abuse 0.4%
Hypertension 0.4%
Immunosuppression 0.4%
Hypovolaemia 10.5%
Suicide Attempt 10.5%
Pulmonary Embolism 7.9%
Delusion 5.3%
Gestational Diabetes 5.3%
Hyponatraemia 5.3%
Mononeuropathy Multiplex 5.3%
Parkinsonism 5.3%
Psychotic Disorder 5.3%
Somnolence 5.3%
Tremor 5.3%
Weight Increased 5.3%
White Blood Cell Count Increased 5.3%
Back Pain 2.6%
Cardiac Failure 2.6%
Chronic Obstructive Pulmonary Disease 2.6%
Coagulation Test Abnormal 2.6%
Coma 2.6%
Completed Suicide 2.6%
Convulsion 2.6%
Concomitant
Product Used For Unknown Indication 36.8%
Schizophrenia 21.0%
Depression 5.9%
Drug Use For Unknown Indication 5.0%
Agitation 3.4%
Anxiety Disorder 2.9%
Atrial Fibrillation 2.9%
Schizophrenia, Paranoid Type 2.9%
Schizoaffective Disorder 2.7%
Psychotic Disorder 2.3%
Anxiety 2.0%
Multiple Sclerosis 2.0%
Hypertension 1.6%
Smoking Cessation Therapy 1.6%
Schizophrenia, Disorganised Type 1.4%
Sleep Disorder 1.4%
Cardiac Flutter 1.1%
Insomnia 1.1%
Pain 1.1%
Affective Disorder 0.9%
Weight Increased 11.7%
Hypertension 7.4%
White Blood Cell Count Increased 7.4%
Electrocardiogram Abnormal 6.4%
Intentional Overdose 6.4%
Petechiae 6.4%
Neuroleptic Malignant Syndrome 5.3%
Abortion Spontaneous 4.3%
Death 4.3%
Drug Ineffective 4.3%
Mood Altered 4.3%
Urinary Retention 4.3%
Visual Acuity Reduced 4.3%
Vomiting 4.3%
Cardiac Disorder 3.2%
Sleep Disorder 3.2%
Tetany 3.2%
Troponin T Increased 3.2%
Type 1 Diabetes Mellitus 3.2%
White Blood Cell Count Decreased 3.2%